Therapeutic hypothermia (TH) involves cooling newborn infants to 33-35°C for 72 hours to reduce brain injury from hypoxic-ischemic encephalopathy (HIE). The Mira Cradle is a device developed to provide TH using phase change materials (PCMs) to maintain the target temperature. PCMs called FS21 and FS29 are used to induce and sustain hypothermia. The infant is monitored closely during the 72 hour cooling period and then slowly rewarmed over 6-8 hours. TH has been shown to improve outcomes for infants with moderate to severe HIE.
2. Objectives
• Therapeutic hypothermia (TH)
• Selection criteria for TH
• Contraindication
• Monitoring of the infant
• Systemic care of patients during TH
• Mira Cradle
• Re-warming
• TH prior to and during transport
7/29/2022
3. Introduction
• Neonatal hypoxic encephalopathy is a neurological
emergency
• Peripartum asphyxia affects 3 to 5 newborns per
1000 live births with subsequent hypoxic ischemic
encephalopathy (HIE) in 0.5 to 1 per 1000 live
births (Levene 1986)
• N Gunn (1997): 60% LTND if:
HIE
Seizures
4. • Biphasic nature of cell death Gluckman PD, et al 1992
• Primary neuronal death (cell hypoxia/primary energy
failure)
• Latent period – 6 hours
• Secondary phase – delayed neuronal death begins
9. History
• 1803 “Russian Method of Resuscitation” consisted of
burying the victim of a cardiac arrest in snow hoping
for ROSC
7/29/2022
10. • James Miller and Bjorn Westin in the 1950s
developed a scientific rationale for the use of
hypothermia in "asphyxia neonatorum” in first case
series
• In 1959, Benson et al, case series of 19 patient post
cardiac arrest
11. • Animal Studies
• Preservation of architecture in cortex of cooled fetal
sheep (Gunn et al J of ClinInv 1997)
• Control Cooled
12. • Mariane Thorensen - Intrigued by stories of children
who fell through Norwegian ice and suffered
prolonged drowning in iced water emerged with
preserved cerebral function
13. • Infants ≥ 36 weeks gestational age with moderate to
severe neonatal encephalopathy
• Intervention- Brain cooling vs conventional treatment
• Outcome:
Death
Neurodevelopmental disability
Combined outcome
14. • TH is defined as moderate hypothermia when where
the core body temperature measured by esophageal
or rectal probe is cooled down to 33.0–35°C for 72 h
followed by slow re-warming (0.2–0.5°C/h)
15.
16. Total body hypothermia for neonatal encephalopathy
TOBY-n= 325
• Cooled to 33C - 34C for 72 hours or usual care.
• Primary outcome: death or severe neurodevelopmental
disability at 18 months occurred in 53% of the usual care group
and 45% of the cooled group ([RR] 0.86 [0.68–1.07], P = .17).
• Predefined secondary outcomes: survival without disabilities
significantly higher in the cooled vs. the usual care group. The
rate of CP was low, improved mental and psychomotor indices
were noted in the cooled vs. the usual care group (P<.05)
7/29/2022
23. Inclusion Criteria
Infant > 36 weeks gestation and least one
• Apgar score of ≤5 at 10 minutes
• Continued need for assisted ventilation at 10 mins
• Acidosis (umbilical cord ph or arterial ph <7.00)
• Base deficit ≥16 mmol/L
• Moderate to severe encephalopathy with or without
seizures or the presence of one or more signs in 3 of 6
categories on the chart (modified Sarnat score)
29. • It has been developed in collaboration with CMC,
Vellore
• Components
Cradle
Phase change material
Conduction mattress
• Associated equipments
7/29/2022
30. • Cradle
Exoskeleton of the device
Provides insulation to the PCM mattress from
ambient temperature
7/29/2022
31. • Phase Change Materials (PCMs) are special thermal
energy storage materials
• It uses chemical bonds to store and release heat
• Properties- Consistency
Constant Temperature
High Latent heat energy storage capacity
• Two PCMs
FS21
FS29
32.
33. FS29
• Nominal freezing and melting temperature of 29° c
• It retains its form and shape
• Six units are provided
• Charging time 8-10 hours when stored in bottom part
of the refrigerator
34. 7/29/2022
• Used in maintaining and sustaining hypothermia
• Three units to be used
• Not required to be replaced during 72 hours process
• Other three units should be kept on standby
35. FS21
• Nominal freezing and melting temperature of 21°c
• It retains its form and shape
• Two units are provided
• Charging time 6-8 hours when stored in bottom part
of the refrigerator
36. • Used in conjunction with FS29
• Used to induce hypothermia
• Used to control temperature ( when newborn temperature
starts drifting above 33.8 c)
37. Conduction mattress
• Gel based, wt-1.2kg
• Enhances heat transfer
• Provides smooth surface for newborn to lie
• Store- room temperature
• Flat and uniform before use
38. Use
Before use
• Clean components with hospital approved
disinfectant
• Remove cloth bag and ensure PCMs are hard and
rigid
• Ensure that PCMs and conduction mattress are not
leaking
• Ensure the temperature of FS29
39. Checking FS29
• Should feel hard and rigid
• Temperature indicator
• Three units to be placed at the bottom
7/29/2022
42. Preparing associated equipments
• Thin clean bed shit
• Warmer- switch of the warmer and later to be used
in manual mode
• Rectal probe- insert 3-5cm within the rectum to
monitor core temperature
• Multiparameter- set temperature alarm limits of 33.2-
33.8 c
• NICU temperature 24-30 C
46. Re-warming phase
• Target re-warming rate -0.2°C/hour
• Target re-warming temperature- 36.5°C
• During re-warming phase, do not remove infant from
Mira cradle
• Use warmer in manual mode only
47. Steps
• Cover newborn with sheet
• Turn on warmer with 10-30% output
• Record temperature every hour
• If rate is higher- switch of the warmer
• Once the temperature is 36.5°C
remove infant from Mira cradle
• Monitor temperature for next 8 hours
49. Respiratory management
• Hypocarbia and hyperoxia have shown to increase
neuronal injury in asphyxiated newborns
• Thoresen et al. suggest to aim for PaCO2 levels of 41–50
mmHg
• Effects of whole body hypothermia on lung mechanics
• hypothermia causes a leftward shift in the hemoglobin-
oxygen dissociation curve
50. Circulatory management
• Effects of TH on heart are bradycardia and
decreased cardiac output
• Sinus bradycardia -slower activity of atrial
pacemaker and intracardiac conduction
• Cardioprotective effect
7/29/2022
51. • Effect of TH on mesenteric circulation is unclear
• Enteral nutrition is generally delayed until rewarming
• HIE itself cause renal failure or SIADH resulting in
oligo-anuria which may necessitate fluid restriction to
avoid volume overload and brain edema
• TH may be associated with “cold diuresis” in the
adult
52. Hematological aspects
• TH is also known to cause platelet dysfunction, and
thrombocytopenia and
Electrolyte monitoring
• Dilutional hyponatremia
• Intracellular potassium shift
Glucose management
• Hyperglycemia due to stress hormones followed by
• Hypoglycemia due to depleted liver glycogen
53. Subcutaneous fat necrosis
• TH has association with SCFN
• Self-limited condition
• SCFN usually appears within 1st week of life,
hypercalcemia may even occur months later
• May cause refractory hypercalcemia sometimes resulting
in nephrocalcinosis
54. Drug metabolism
• TH causes delayed metabolism of drugs -
phenobarbital, morphine, and vecuronium
• Gentamicin metabolism has been studied during TH
and 36 h dosing interval has been found to result in
acceptable trough levels with desired efficacy
56. Stop cooling before 72 hours if
• Persistent hypoxemia with 100% Fio2
• Life threatening coagulopathy
• Arrhythmia requiring medical treatment
• Decision on withdrawal of care
7/29/2022
57. Maintenance
Storage
• Store in refrigerator
• Charge for 8-10 hours
• Do not fold/bend/distort
• Store on flat surface
• Do not stack one above other
• When not in use, should be kept in cloth bag
provided
58. Periodic calibration check
• Once a month, cross check indicator temperature
manually
• Temperature difference of 1C is acceptable
• If difference is >1c, then contact company for
replacement
7/29/2022
60. Cooling during transport
• passive cooling allows safe controlled cooling to begin prior to
the arrival of the baby in the cooling centre
7/29/2022
After a latent period of at least six hours, the secondary phase of ’delayed neuronal death’ begins (Williams 1991).
Perinatal acidemia
itself has been found to be associated with abnormal outcome
in 20% of the otherwise mild HIE appearing newborns.
[16]
Profound postnatal acidosis (pH < 7.00) within 1st h afte
birth has also been found to be predictive of bad outcome
and early indication for potential TH.
sinus bradycardia secondary to the slower activity of atrial pacemaker and intracardiac conduction.
Biomarkers such as cardiac troponin I, CPK‑myocardium
bound (CPK‑MB), B type natriuretic peptide (BNP)[38]
are additional parameters that can be followed during the
course of treatment. Both troponin and CPK‑MB increase
in HIE depending on the extent of injury to the heart and
then decrease gradually. TH has been shown to prevent the
excessive increase in troponin which can be interpreted as
1.Azzopardi suggests feeding cautiously after 24 h even during TH.
2. It is most likely due to nonosmotic suppression of vasopressin during cold exposure.